2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid

Star0

DB06985ExperimentalSmall molecule

2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid: Overview.

Formula / weight: C₂₀H₁₉F₃N₂O₃ · 392.3717 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL1230001PubChem25138295

Structure

InChIKeyMEAQCLPMSVEOQF-UHFFFAOYSA-NSMILESOC(=O)C1=C(NC(=O)N2CCC(CC2)C2=C(C=CC=C2)C(F)(F)F)C=CC=C1

What you can answer from here — as of April 02, 2025

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of 2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account